Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
64
-
Total shares
-
13.3M
-
Shares change
-
+362K
-
Total reported value, excl. options
-
$52.5M
-
Value change
-
+$1.09M
-
Put/Call ratio
-
1.29
-
Number of buys
-
21
-
Number of sells
-
-31
-
Price
-
$3.95
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2017
65 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2017.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), Cormorant Asset Management, LLC (1.69M shares), BlackRock Inc. (1.57M shares), VANGUARD GROUP INC (1.54M shares), venBio Select Advisor LLC (1.19M shares), Intellectus Partners, LLC (1.1M shares), STATE STREET CORP (513K shares), GEODE CAPITAL MANAGEMENT, LLC (367K shares), NORTHERN TRUST CORP (347K shares), and FRANKLIN RESOURCES INC (289K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.